ArticleAging and health research2026
Trends and disparities in cardiometabolic disease prevalence by physical activity among US adults: NHANES 2007-2018.
Article in Aging and health research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Background: Cardiometabolic diseases (CMDs) significantly contribute to U.S. morbidity. Physical activity (PA) is associated with lower CMD prevalence, yet trends in CMD prevalence by PA level and associated disparities remain underexplored. Methods: We analyzed 2007-2018 NHANES data from 26,380 adults aged ≥20 years. CMDs included diabetes, cardiovascular disease (CVD), and chronic kidney disease (CKD; eGFR <60 mL/min/1.73 m Results: Diabetes prevalence increased, with higher odds in 2013-2014 (OR = 1.27; 95% CI: 1.01-1.60), 2015-2016 (OR = 1.41; 1.08-1.84), and 2017-2018 (OR = 1.45; 1.16-1.80) and an absolute increase of 2.49% (0.85 to 4.13). No significant trends were observed for CKD (absolute change: 0.11%; -1.57 to 1.80) or CVD (0.10%; -1.40 to 1.59). CMD prevalence was highest among those with no activity and lowest among regular activity. Regular PA was associated with lower odds of diabetes (aOR = 0.70; 0.62-0.79), CKD (aOR = 0.74; 0.65-0.83), and CVD (aOR = 0.75; 0.64-0.87); some/irregular activity was associated with lower odds of CVD only (aOR = 0.72; 0.62-0.85). Non-Hispanic Blacks had the highest CKD and CVD prevalence across PA levels; diabetes prevalence was highest among Mexican Americans with regular activity. Conclusion: Diabetes prevalence increased significantly, while CKD and CVD prevalence remained stable. Guideline-adherent PA is associated with lower CMD odds, yet disparities underscore the need for equity-driven, culturally tailored PA promotion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.